Literature DB >> 25351205

Variation in genomic landscape of clear cell renal cell carcinoma across Europe.

Ghislaine Scelo1, Yasser Riazalhosseini2, Liliana Greger3, Louis Letourneau4, Mar Gonzàlez-Porta3, Magdalena B Wozniak1, Mathieu Bourgey4, Patricia Harnden5, Lars Egevad6, Sharon M Jackson5, Mehran Karimzadeh2, Madeleine Arseneault2, Pierre Lepage4, Alexandre How-Kit7, Antoine Daunay7, Victor Renault7, Hélène Blanché7, Emmanuel Tubacher7, Jeremy Sehmoun7, Juris Viksna8, Edgars Celms8, Martins Opmanis8, Andris Zarins8, Naveen S Vasudev5, Morag Seywright9, Behnoush Abedi-Ardekani1, Christine Carreira1, Peter J Selby5, Jon J Cartledge10, Graham Byrnes1, Jiri Zavadil1, Jing Su3, Ivana Holcatova11, Antonin Brisuda12, David Zaridze13, Anush Moukeria13, Lenka Foretova14, Marie Navratilova14, Dana Mates15, Viorel Jinga16, Artem Artemov17, Artem Nedoluzhko18, Alexander Mazur17, Sergey Rastorguev18, Eugenia Boulygina18, Simon Heath19, Marta Gut19, Marie-Therese Bihoreau20, Doris Lechner20, Mario Foglio20, Ivo G Gut19, Konstantin Skryabin21, Egor Prokhortchouk21, Anne Cambon-Thomsen22, Johan Rung3, Guillaume Bourque2, Paul Brennan1, Jörg Tost20, Rosamonde E Banks5, Alvis Brazma3, G Mark Lathrop23.   

Abstract

The incidence of renal cell carcinoma (RCC) is increasing worldwide, and its prevalence is particularly high in some parts of Central Europe. Here we undertake whole-genome and transcriptome sequencing of clear cell RCC (ccRCC), the most common form of the disease, in patients from four different European countries with contrasting disease incidence to explore the underlying genomic architecture of RCC. Our findings support previous reports on frequent aberrations in the epigenetic machinery and PI3K/mTOR signalling, and uncover novel pathways and genes affected by recurrent mutations and abnormal transcriptome patterns including focal adhesion, components of extracellular matrix (ECM) and genes encoding FAT cadherins. Furthermore, a large majority of patients from Romania have an unexpected high frequency of A:T>T:A transversions, consistent with exposure to aristolochic acid (AA). These results show that the processes underlying ccRCC tumorigenesis may vary in different populations and suggest that AA may be an important ccRCC carcinogen in Romania, a finding with major public health implications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25351205     DOI: 10.1038/ncomms6135

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  72 in total

1.  Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomy.

Authors:  Daniel M Tennenbaum; Brandon J Manley; Emily Zabor; Maria F Becerra; Maria I Carlo; Jozefina Casuscelli; Almedina Redzematovic; Nabeela Khan; Maria E Arcila; Martin H Voss; Darren R Feldman; Robert J Motzer; Nicole E Benfante; Jonathan A Coleman; Paul Russo; James J Hsieh; Abraham Ari Hakimi
Journal:  Urol Oncol       Date:  2017-04-10       Impact factor: 3.498

2.  GHSR hypermethylation: a promising pan-cancer marker.

Authors:  Pouria Jandaghi; Jörg D Hoheisel; Yasser Riazalhosseini
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations.

Authors:  Brandon J Manley; Ed Reznik; Mazyar Ghanaat; Mahyar Kashan; Maria F Becerra; Jozefina Casuscelli; Daniel Tennenbaum; Almedina Redzematovic; Maria I Carlo; Yusuke Sato; Maria Arcila; Martin H Voss; Darren R Feldman; Robert J Motzer; Paul Russo; Jonathan Coleman; James J Hsieh; Ari A Hakimi
Journal:  Urol Oncol       Date:  2017-11-11       Impact factor: 3.498

4.  Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

Authors:  Brandon John Manley; Emily C Zabor; Jozefina Casuscelli; Daniel M Tennenbaum; Almedina Redzematovic; Maria F Becerra; Nicole Benfante; Yusuke Sato; Teppei Morikawa; Haruki Kume; Masashi Fukayama; Yukio Homma; Seishi Ogawa; Maria E Arcila; Martin H Voss; Darren R Feldman; Jonathan A Coleman; Victor E Reuter; Robert J Motzer; Paul Russo; James J Hsieh; A Ari Hakimi
Journal:  Eur Urol Focus       Date:  2016-07-16

5.  International cancer seminars: a focus on kidney cancer.

Authors:  G Scelo; J N Hofmann; R E Banks; P Bigot; R S Bhatt; G Cancel-Tassin; S K Chew; C J Creighton; O Cussenot; I J Davis; B Escudier; T M Frayling; C Häggström; M A T Hildebrandt; I Holcatova; M Johansson; W M Linehan; D F McDermott; K L Nathanson; S Ogawa; E J Perlman; M P Purdue; P Stattin; C Swanton; N S Vasudev; X Wu; A Znaor; P Brennan; S J Chanock
Journal:  Ann Oncol       Date:  2016-04-29       Impact factor: 32.976

6.  Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.

Authors:  Xavier Castells; Sandra Karanović; Maude Ardin; Karla Tomić; Evanguelos Xylinas; Geoffroy Durand; Stephanie Villar; Nathalie Forey; Florence Le Calvez-Kelm; Catherine Voegele; Krešimir Karlović; Maja Mišić; Damir Dittrich; Igor Dolgalev; James McKay; Shahrokh F Shariat; Viktoria S Sidorenko; Andrea Fernandes; Adriana Heguy; Kathleen G Dickman; Magali Olivier; Arthur P Grollman; Bojan Jelaković; Jiri Zavadil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-17       Impact factor: 4.254

Review 7.  Precision medicine from the renal cancer genome.

Authors:  Yasser Riazalhosseini; Mark Lathrop
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

Review 8.  Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact.

Authors:  Brandon J Manley; Abraham Ari Hakimi
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

9.  Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells.

Authors:  Keiji Hashimoto; Irina N Zaitseva; Radha Bonala; Sivaprasad Attaluri; Katherine Ozga; Charles R Iden; Francis Johnson; Masaaki Moriya; Arthur P Grollman; Viktoriya S Sidorenko
Journal:  Carcinogenesis       Date:  2016-04-18       Impact factor: 4.944

10.  New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.

Authors:  Byeong Hwa Yun; Viktoriya S Sidorenko; Thomas A Rosenquist; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Toxicol Res (Camb)       Date:  2015-07-01       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.